May-03-24 12:21PM
|
|
May-02-24 03:33PM
|
|
May-01-24 11:15AM
|
|
09:14AM
|
|
07:39AM
|
(Thomson Reuters StreetEvents) |
03:35AM |
Loading… |
03:35AM
|
|
12:00AM
|
|
Apr-30-24 08:57PM
|
|
06:30PM
|
|
05:35PM
|
|
05:26PM
|
|
04:19PM
|
(Associated Press Finance) |
04:05PM
|
|
Apr-27-24 07:00AM
|
|
Apr-16-24 04:05PM
|
|
08:13AM |
Loading… |
Mar-28-24 08:13AM
|
|
Mar-23-24 05:06AM
|
|
Mar-17-24 08:50AM
|
|
Mar-08-24 09:38AM
|
|
08:15AM
|
|
Mar-07-24 11:31AM
|
|
10:08AM
|
|
Mar-06-24 04:45PM
|
|
Mar-04-24 07:06PM
|
|
Mar-02-24 05:06AM
|
|
Feb-27-24 04:05PM
|
|
08:00AM
|
|
Feb-26-24 07:42AM
|
|
Feb-23-24 01:11PM
|
|
Feb-19-24 08:00AM
|
|
08:30AM |
Loading… |
Feb-14-24 08:30AM
|
|
01:47AM
|
|
Feb-13-24 08:00AM
|
|
Feb-12-24 09:35AM
|
|
Feb-10-24 05:06AM
|
|
Feb-09-24 09:35AM
|
|
Feb-08-24 06:50PM
|
|
09:35AM
|
|
Feb-07-24 07:01PM
|
(Morningstar Research) -7.56% |
01:13PM
|
|
10:47AM
|
|
09:45AM
|
(Thomson Reuters StreetEvents) |
Feb-06-24 08:45PM
|
|
06:30PM
|
|
05:25PM
|
|
05:01PM
|
|
04:33PM
|
(Associated Press Finance) |
04:05PM
|
|
Feb-01-24 04:05PM
|
|
Jan-30-24 10:00AM
|
|
Jan-29-24 09:40AM
|
|
Jan-25-24 08:00AM
|
|
Jan-23-24 04:05PM
|
|
Jan-22-24 05:00PM
|
|
Jan-21-24 01:16PM
|
|
Jan-19-24 11:21AM
|
|
Jan-18-24 04:05PM
|
|
04:00PM
|
|
Jan-17-24 11:29AM
|
|
Jan-11-24 09:40AM
|
|
Jan-08-24 04:40PM
|
(Investor's Business Daily) |
12:43PM
|
|
06:12AM
|
|
Jan-07-24 04:00PM
|
|
Jan-02-24 04:05PM
|
|
Dec-19-23 10:16AM
|
|
Dec-12-23 08:54AM
|
|
Dec-07-23 04:05PM
|
|
Dec-05-23 01:51PM
|
|
Dec-04-23 07:26PM
|
|
08:02AM
|
|
08:00AM
|
|
Dec-01-23 11:32AM
|
|
Nov-29-23 10:45AM
|
|
Nov-21-23 04:05PM
|
|
Nov-17-23 01:33PM
|
|
Nov-10-23 09:00AM
|
|
Nov-09-23 04:43PM
|
|
Nov-08-23 05:24PM
|
|
05:19AM
|
|
Nov-06-23 09:47AM
|
|
Nov-03-23 12:11PM
|
|
Nov-02-23 11:23AM
|
|
12:30AM
|
|
Nov-01-23 07:00PM
|
|
06:05PM
|
|
04:05PM
|
|
Oct-30-23 10:00AM
|
|
Oct-28-23 05:06AM
|
|
Oct-27-23 04:58AM
|
|
Oct-26-23 10:02AM
|
|
Oct-25-23 10:01AM
|
|
08:30AM
|
|
Oct-22-23 02:30AM
|
|
Oct-19-23 06:51PM
|
|
08:15AM
|
|
Oct-18-23 04:05PM
|
|
08:30AM
|
|
Oct-12-23 11:40AM
|
|
Oct-09-23 02:03AM
|
|
|
|
|
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Garber Alan M | Director | Mar 21 '24 | Option Exercise | 19.57 | 23,491 | 459,719 | 54,908 | Mar 25 07:31 PM | Garber Alan M | Director | Mar 21 '24 | Sale | 24.01 | 19,205 | 461,112 | 35,703 | Mar 25 07:31 PM | Haley Patrick J. | EVP, Commercial | Feb 23 '24 | Sale | 21.45 | 47,020 | 1,008,579 | 384,866 | Feb 27 06:58 PM | JOHNSON DAVID EDWARD | Director | Feb 21 '24 | Buy | 20.70 | 190,000 | 3,932,734 | 1,100,730 | Feb 22 05:08 PM | Haley Patrick J. | EVP, Commercial | Dec 14 '23 | Option Exercise | 16.29 | 50,000 | 814,500 | 357,687 | Dec 14 07:56 PM | Haley Patrick J. | EVP, Commercial | Dec 14 '23 | Sale | 23.35 | 50,000 | 1,167,500 | 307,687 | Dec 14 07:56 PM | Hessekiel Jeffrey | EVP, General Counsel & Sec | Dec 13 '23 | Sale | 23.01 | 25,000 | 575,250 | 533,345 | Dec 14 07:55 PM | Haley Patrick J. | EVP, Commercial | Dec 12 '23 | Sale | 22.50 | 14,149 | 318,352 | 307,687 | Dec 14 07:56 PM | Hessekiel Jeffrey | EVP, General Counsel & Sec | Dec 04 '23 | Sale | 22.06 | 25,000 | 551,500 | 558,345 | Dec 04 06:22 PM | Hessekiel Jeffrey | EVP, General Counsel & Sec | Nov 30 '23 | Sale | 22.01 | 25,000 | 550,250 | 583,345 | Dec 04 06:22 PM | JOHNSON DAVID EDWARD | Director | Nov 27 '23 | Buy | 21.61 | 120,409 | 2,602,038 | 910,730 | Nov 29 04:30 PM | JOHNSON DAVID EDWARD | Director | Nov 27 '23 | Sale | 21.61 | 120,409 | 2,602,038 | 790,321 | Nov 29 04:30 PM | Aftab Dana | CSO/EVP Disc & Trans Research | Aug 30 '23 | Sale | 22.47 | 4,600 | 103,362 | 399,943 | Sep 01 08:15 PM | MORRISSEY MICHAEL | President and CEO | Aug 28 '23 | Option Exercise | 15.31 | 360,000 | 5,511,600 | 945,496 | Aug 30 09:48 PM | Senner Christopher J. | EVP and CFO | Aug 04 '23 | Option Exercise | 14.74 | 60,000 | 884,400 | 631,631 | Aug 07 09:20 PM | Senner Christopher J. | EVP and CFO | Aug 04 '23 | Sale | 20.68 | 60,000 | 1,240,800 | 571,631 | Aug 07 09:20 PM | Senner Christopher J. | EVP and CFO | Aug 03 '23 | Option Exercise | 14.74 | 60,000 | 884,400 | 631,631 | Aug 07 09:20 PM | Senner Christopher J. | EVP and CFO | Aug 03 '23 | Sale | 20.51 | 60,000 | 1,230,600 | 571,631 | Aug 07 09:20 PM | Haley Patrick J. | EVP, Commercial | Aug 03 '23 | Sale | 20.67 | 30,553 | 631,531 | 285,467 | Aug 07 08:24 PM | Hessekiel Jeffrey | EVP, General Counsel & Sec | Aug 01 '23 | Option Exercise | 14.74 | 55,710 | 821,165 | 627,686 | Aug 03 08:02 PM | Hessekiel Jeffrey | EVP, General Counsel & Sec | Aug 01 '23 | Sale | 19.63 | 55,710 | 1,093,587 | 571,976 | Aug 03 08:02 PM |
|